The aim of this study is to test the efficacy and safety of evacetrapib. This study will include blood draws, physical exams, vital signs, urine collection, EKGs and study drug dispensing. All study related testing will be completed at no cost to the patient. Compensation may occur for qualified patients.
- Patient Population – Patients with high-risk vascular disease (HRVD.)
- Sponsor – Eli Lilly
- Contact Information – (402) 384 – 2705, MPCHeartConsultantsResearch@nmhs.org
- View this study on ClinicalTrials.gov